Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC
Abstract Background Recent researches suggested that statins, beside their role in inhibiting endogenous cholesterol synthesis and in cardiovascular prevention, could influence several processes in cancer biology. In fact, a recent meta‐analysis demonstrated that statins could positively influence O...
Main Authors: | Alessandro Rossi, Marco Filetti, Beatrice Taurelli Salimbeni, Marta Piras, Francesco Rizzo, Raffaele Giusti, Paolo Marchetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Cancer Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/cnr2.1368 |
Similar Items
-
Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma
by: Jiao Wang, et al.
Published: (2024-02-01) -
Gut resistome of NSCLC patients treated with immunotherapy
by: Ewelina Iwan, et al.
Published: (2024-08-01) -
Impact of NSCLC metabolic remodeling on immunotherapy effectiveness
by: Lulu Lv, et al.
Published: (2022-08-01) -
The Landscape of Immunotherapy Resistance in NSCLC
by: Daniele Frisone, et al.
Published: (2022-04-01) -
The role of chemoradiotherapy and immunotherapy in stage III NSCLC
by: Zsuzsanna Orosz, et al.
Published: (2024-04-01)